Fanconi anemia: A signal transduction and DNA repair pathway

Yale Journal of Biology and Medicine

Volumn 86, Issue 4, 2013, Pages 491-497

  Kupfer, Gary M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow failure; DNA repair; Fanconi anemia

Indexed keywords

BRCA2 PROTEIN; DNA; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP E PROTEIN; FANCONI ANEMIA GROUP F PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; FANCONI ANEMIA PROTEIN; PROTEINFANCB; PROTEINFANCI; PROTEINFANCJ; PROTEINFANCM; PROTEINFANCN; PROTEINFANCO; PROTEINFANCP; RAD51 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL FEATURE; DNA REPAIR; FANCONI ANEMIA; HISTOPATHOLOGY; HUMAN; MISMATCH REPAIR; MOLECULAR BIOLOGY; MOLECULAR PATHOLOGY; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UBIQUITINATION;

BONE MARROW FAILURE; DNA REPAIR; FANCONI ANEMIA;

CDC2 PROTEIN KINASE; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; HUMANS; PHOSPHORYLATION; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 84891063166     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Alter BP. Fanconi's anemia, transplantation, and cancer. Pediatr Transplant. 2005;9 Suppl 7:81-86. [PubMed]
2. Lowy DR, Gillison ML. A new link between Fanconi anemia and human papillomavirus-associated malignancies. J Natl Cancer Inst. 2003;95(22):1648-1650. [PubMed]
3. Masserot C, Peffault de Latour R, Rocha V, Leblanc T, Rigolet A, Pascal F. et al. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation. Cancer. 2008;113(12):3315-3322. [PubMed]
4. Bagby GC, Alter BP. Fanconi anemia. Semin Hematol. 2006;43(3):147-156. [PubMed]
5. Tischkowitz M, Dokal I. Fanconi anaemia and leukaemia - clinical and molecular aspects. Br J Haematol. 2004;126(2):176-191. [PubMed]
6. Hirschhorn R. In vivo reversion to normal of inherited mutations in humans. J Med Genet. 2003;40(10):721-728. [PMC free article] [PubMed]
7. Soulier J, Leblanc T, Larghero J, Dastot H, Shimamura A, Guardiola P. et al. Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. Blood. 2005;105(3):1329-1336. [PubMed]
8. Velez-Ruelas MA, Martinez-Jaramillo G, Arana-Trejo RM, Mayani H. Hematopoietic changes during progression from Fanconi anemia into acute myeloid leukemia: case report and brief review of the literature. Hematology. 2006;11(5):331-334. [PubMed]
9. Rochowski A, Olson SB, Alonzo TA, Gerbing RB, Lange BJ, Alter BP. Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AML. Pediatr Blood Cancer. 2012;59(5):922-924. [PMC free article] [PubMed]
10. Mehta PA, Ileri T, Harris RE, Williams DA, Mo J, Smolarek T. et al. Chemotherapy for myeloid malignancy in children with Fanconi anemia. Pediatr Blood Cancer. 2007;48(7):668-672. [PubMed]
11. Cantor SB, Guillemette S. Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1. Future Oncol. 2011;7(2):253-261. [PMC free article] [PubMed]
12. Coulet F, Fajac A, Colas C, Eyries M, Dion-Miniere A, Rouzier R. et al. Germline RAD51C mutations in ovarian cancer susceptibility. Clin Genet. 2013;83(4):332-336. [PubMed]
13. Kobayashi H, Ohno S, Sasaki Y, Matsuura M. Hereditary breast and ovarian cancer susceptibility genes (Review) Oncol Rep. 2013 Jun 19; Epub ahead of print. [PubMed]
14. Tischkowitz M, Xia B. PALB2/FANCN: recombining cancer and Fanconi anemia. Cancer Res. 2010;70(19):7353-7359. [PMC free article] [PubMed]
15. Meyer S, Fergusson WD, Whetton AD, Moreira-Leite F, Pepper SD, Miller C. et al. Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption. Genes Chromosomes Cancer. 2007;46(4):359-372. [PubMed]
16. Farzin A, Davies SM, Smith FO, Filipovich A, Hansen M, Auerbach AD. et al. Matched sibling donor haematopoietic stem cell transplantation in Fanconi anaemia: an update of the Cincinnati Children's experience. Br J Haematol. 2007;136(4):633-640. [PubMed]
17. Pasquini R, Carreras J, Pasquini MC, Camitta BM, Fasth AL, Hale GA. et al. HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. Biol Blood Marrow Transplant. 2008;14(10):1141-1147. [PMC free article] [PubMed]
18. Gluckman E, Wagner JE. Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome. Bone Marrow Transplant. 2008;41(2):127-132. [PubMed]
19. Chaudhury S, Auerbach AD, Kernan NA, Small TN, Prockop SE, Scaradavou A. et al. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia. Br J Haematol. 2008;140(6):644-655. [PubMed]
20. Kelly PF, Radtke S, von Kalle C, Balcik B, Bohn K, Mueller R. et al. Stem cell collection and gene transfer in Fanconi anemia. Mol Ther. 2007;15(1):211-219. [PubMed]
21. Croop JM. Gene therapy for fanconi anemia. Curr Hematol Rep. 2003;2(4):335-340. [PubMed]
22. Velazquez I, Alter BP. Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. Am J Hematol. 2004;77(3):257-267. [PubMed]
23. Ozenne V, Paradis V, Vullierme MP, Vilgrain V, Leblanc T, Belghiti J. et al. Liver tumours in patients with Fanconi anaemia: a report of three cases. Eur J Gastroenterol Hepatol. 2008;20(10):1036-1039. [PubMed]
24. Bogliolo M, Schuster B, Stoepker C, Derkunt B, Su Y, Raams A. et al. Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am J Hum Genet. 2013;92(5):800-806. [PMC free article] [PubMed]
25. Kottemann MC, Smogorzewska A. Fanconi anaemia and the repair of Watson and Crick DNA crosslinks. Nature. 2013;493(7432):356-363. [PMC free article] [PubMed]
26. Kee Y, D'Andrea AD. Molecular pathogenesis and clinical management of Fanconi anemia. J Clin Invest. 2012;122(11):3799-3806. [PMC free article] [PubMed]
27. Kim H, D'Andrea AD. Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway. Genes Dev. 2012;26(13):1393-1408. [PMC free article] [PubMed]
28. Kim H, Yang K, Dejsuphong D, D'Andrea AD. Regulation of Rev1 by the Fanconi anemia core complex. Nat Struct Mol Biol. 2012;19(2):164-170. [PMC free article] [PubMed]
29. Ho GP, Margossian S, Taniguchi T, D'Andrea AD. Phosphorylation of FANCD2 2011;475(7354):53-58. [PubMed]
30. Mi J, Kupfer GM. The Fanconi anemia core complex associates with chromatin during S phase. Blood. 2005;105(2):759-766. [PubMed]
31. Kupfer GM, Yamashita T, Naf D, Suliman A, Asano S, D'Andrea AD. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2. Blood. 1997;90(3):1047-1054. [PubMed]
32. Mi J, Qiao F, Wilson JB, High AA, Schroeder MJ, Stukenberg PT. et al. FANCG is phosphorylated at serines 383 and 387 during mitosis. Mol Cell Biol. 2004;24(19):8576-8585. [PMC free article] [PubMed]
33. Collins NB, Wilson JB, Bush T, Thomashevski A, Roberts KJ, Jones NJ. et al. ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function. Blood. 2009;113(10):2181-2190. [PMC free article] [PubMed]
34. Zhi G, Wilson JB, Chen X, Krause DS, Xiao Y, Jones NJ. et al. Fanconi anemia complementation group FANCD2 protein serine 331 phosphorylation is important for fanconi anemia pathway function and BRCA2 interaction. Cancer Res. 2009;69(22):8775-8783. [PubMed]
35. Qiao F, Mi J, Wilson JB, Zhi G, Bucheimer NR, Jones NJ. et al. Phosphorylation of fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway. J Biol Chem. 2004;279(44):46035-46045. [PubMed]
36. Williams SA, Longerich S, Sung P, Vaziri C, Kupfer GM. The E3 ubiquitin ligase RAD18 regulates ubiquitylation and chromatin loading of FANCD2 and FANCI. Blood. 2011;117(19):5078-5087. [PMC free article] [PubMed]
37. Williams SA, Wilson JB, Clark AP, Mitson-Salazar A, Tomashevski A, Ananth S. et al. Functional and physical interaction between the mismatch repair and FA-BRCA pathways. Hum Mol Genet. 2011;20(22):4395-4410. [PMC free article] [PubMed]